Ratings Traumhaus AG Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 10:47:58 2024-04-18 am EDT			5-day change	1st Jan Change
0.21 ^EUR	+22.81%		0.00%	-17.32%

2023	Traumhaus AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2023	Traumhaus AG Provides Sales Guidance for the Year 2023	CI

The company presents an interesting fundamental situation from a short-term investment perspective.

Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 69% by 2025.
The company shows low valuation levels, with an enterprise value at 0.42 times its sales.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the past twelve months, EPS forecast has been revised upwards.

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality